Please login to the form below

Not currently logged in
Email:
Password:

Forendo Pharma

This page shows the latest Forendo Pharma news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    For an indepth analysis of these deals, read'Pharma deals during October 2014'. ... 335. Forendo Pharma/Apricus Biosciences. Licence [A]. Fispemifene a selective oestrogen modulator in P2 for secondary hypogonadism.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • David Colpman joins Forendo Pharma’s board David Colpman joins Forendo Pharma’s board

    He becomes a non-executive director. Forendo Pharma, a drug development company, has appointed David Colpman to its board of directors. ... Risto Lammintausta, chief executive officer of Forendo Pharma, said: “We are delighted to welcome David with his

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Page & Page and Partners

For those who can imagine better, Page & Page and Partners (P&P) is home to meaningful encounters of a marketing, communication...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics